Crinetics Pharmaceuticals, Inc (CRNX) insider trading
Every open-market stock purchase and sale by Crinetics Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $6.4M over the last 12 months (11 sales). No open-market buys.
- Last insider buy: Coelho Rogerio Vivaldi (Director), $110K, 3 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $6.4M (11 sales). Last close $32.92 on Jun 4, 2026.
Recent CRNX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 18, 2026 | Caren Deardorf (Director) | Bought (not open market) | — |
| Jun 18, 2026 | Camille L Bedrosian (Director) | Bought (not open market) | — |
| Jun 18, 2026 | Wendell Wierenga (Director) | Bought (not open market) | — |
| Jun 18, 2026 | Coelho Rogerio Vivaldi (Director) | Bought (not open market) | — |
| Jun 18, 2026 | Coelho Rogerio Vivaldi (Director) | Bought (not open market) | — |
| Jun 18, 2026 | Weston Nichols (Director) | Bought (not open market) | — |
| Jun 18, 2026 | Weston Nichols (Director) | Bought (not open market) | — |
| Jun 18, 2026 | Matthew K Fust (Director) | Bought (not open market) | — |
| Jun 18, 2026 | Matthew K Fust (Director) | Bought (not open market) | — |
| Jun 18, 2026 | Caren Deardorf (Director) | Bought (not open market) | — |
| Jun 18, 2026 | Stephanie Okey (Director) | Bought (not open market) | — |
| Jun 18, 2026 | Stephanie Okey (Director) | Bought (not open market) | — |
| Jun 18, 2026 | Camille L Bedrosian (Director) | Bought (not open market) | — |
| Jun 18, 2026 | Wendell Wierenga (Director) | Bought (not open market) | — |
| Jun 17, 2026 | Stephanie Okey (Director) | Sold | $224K |
| Jun 17, 2026 | Stephanie Okey (Director) | Sold | $22K |
| May 29, 2026 | Richard Scott Struthers (CEO) | Bought (not open market) | — |
| May 29, 2026 | Richard Scott Struthers (CEO) | Bought (not open market) | — |
| May 29, 2026 | Richard Scott Struthers (CEO) | Bought (not open market) | — |
| Apr 8, 2026 | Jeff E. Knight (Officer) | Sold | $3.4M |
| Apr 8, 2026 | Jeff E. Knight (Officer) | Bought (not open market) | — |
| Apr 8, 2026 | Jeff E. Knight (Officer) | Bought (not open market) | — |
| Apr 8, 2026 | Jeff E. Knight (Officer) | Bought (not open market) | — |
| Mar 16, 2026 | Richard Scott Struthers (CEO) | Sold | $490K |
| Mar 16, 2026 | Richard Scott Struthers (CEO) | Sold | $332K |
Who's trading CRNX
- Camille L Bedrosian, Insider: other filings, last Jun 18, 2026
- Caren Deardorf, Insider: other filings, last Jun 18, 2026
- Matthew K Fust, Director: other filings, last Jun 18, 2026
- Weston Nichols, Insider: other filings, last Jun 18, 2026
- Stephanie Okey, Director: sold $365K (3 sales), last Jun 18, 2026
- Coelho Rogerio Vivaldi, Director: sold $181K (2 sales), last Jun 18, 2026
- Wendell Wierenga, Director: other filings, last Jun 18, 2026
- Richard Scott Struthers, CEO: sold $822K (2 sales), last May 29, 2026
- Jeff E. Knight, COO: sold $3.8M (3 sales), last Apr 8, 2026
- Stephen F. Betz, C-suite exec: sold $397K (2 sales), last Mar 16, 2026
- Tobin Schilke, CFO: sold $266K (1 sale), last Mar 3, 2026
- Isabel Kalofonos, C-suite exec: sold $138K (1 sale), last Feb 23, 2026
- Dana Pizzuti, Officer: sold $438K (3 sales), last Dec 1, 2025
Get free alerts when an insider at Crinetics Pharmaceuticals, Inc files a new trade →